Growing interest is recently being focused on the role played by the platelets in favoring
hepatocellular cancer (HCC) growth and dissemination. The present review reports in detail …

Purpose Systemic inflammatory cell ratio, neutrophil–lymphocyte ratio (NLR), platelet–
lymphocyte ratio (PLR), and lymphocyte–monocyte ratio (LMR) are used as prognostic …

Purpose Early detection and prognostic prediction of hepatocellular carcinoma (HCC)
remain a great challenge. In this study, we explored the role and diagnostic significance of …

Background This study aimed to comprehensively assess the diagnostic value of fibrinogen
to prealbumin ratio (FPR) and gamma-glutamyl transpeptidase to platelet ratio (GPR) as …

Introduction Hepatocellular carcinoma is associated with several chronic inflammatory
conditions. It is increasingly understood that the inflammation may be part of the …

Introduction: Many single and combination blood tests that reflect local or systemic
inflammation have been shown to be useful prognosticators in patients with a variety of …

Introduction: Atezolizumab plus bevacizumab (ATZ+ BV) treatment has become the first-line
regimen for unresectable hepatocellular carcinoma (u-HCC). Prediction of response to it …

Background The purpose of the study was to evaluate the diagnostic value of gamma‐
glutamyl transpeptidase to alkaline phosphatase ratio (GAPR) combined with gamma …

Background Due to the complicated molecular and cellular heterogeneity in hepatocellular
carcinoma (HCC), the morbidity and mortality still remains high level in the world. However …

Objective. To investigate the relationship between blood platelet‐to‐lymphocyte ratio (PLR)
and clinicopathological characteristics of patients with advanced non‐small cell lung cancer …